A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics.
Toki
Shigeru
S
Morinobu
Shigeru
S
Yoshino
Atsuo
A
Yamawaki
Shigeto
S
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000150:complications; D008875:Middle Aged; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000188:drug therapy; D013923:Thromboembolism / Q000139:chemically induced / Q000209:etiology*; D020246:Venous Thrombosis / Q000139:chemically induced / Q000209:etiology*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine